An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
This study compares medication and psychosocial treatments for opioid use disorder, as well as treatments offered at opioid and nonopioid treatment program facilities for commonly co-occurring substance use disorders and mental disorders.
Conflict of Interest Disclosures: Dr Shuey reported receiving grants from the National Institute on Drug Abuse (K12DA050607) during the conduct of the study. Dr Cantor reported receiving grants from the National Institute of Mental Health and the National Institute on Aging outside the submitted work. Dr Anderson reported receiving grants from the American Heart Association and US Deprescribing Research Network; consulting fees from the American Medical Student Association; and fees from the American Medical Association for an editorial position at JAMA Internal Medicine outside the submitted work. No other disclosures were reported.
References
Sordo L, Barrio G, Bravo MJ, et al. . Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. doi:10.1136/bmj.j1550
-
DOI
-
PMC
-
PubMed
Bergman BG, Fallah-Sohy N, Hoffman LA, Kelly JF. Psychosocial approaches in the treatment of opioid use disorders. In: Kelly JF, Wakeman SE, eds. Treating Opioid Addiction. Springer International Publishing; 2019:109-138. doi:10.1007/978-3-030-16257-3_6
-
DOI
Joudrey PJ, Edelman EJ, Wang EA. Methadone for opioid use disorder—decades of effectiveness but still miles away in the US. JAMA Psychiatry. 2020;77(11):1105-1106. doi:10.1001/jamapsychiatry.2020.1511
-
DOI
-
PMC
-
PubMed
Krawczyk N, Rivera BD, Jent V, Keyes KM, Jones CM, Cerdá M. Has the treatment gap for opioid use disorder narrowed in the US? a yearly assessment from 2010 to 2019. Int J Drug Policy. 2022;110:103786. doi:10.1016/j.drugpo.2022.103786
-
DOI
-
PMC
-
PubMed
Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78-82. doi:10.1016/j.drugalcdep.2018.12.030
-
DOI
-
PubMed